Phase 2 Peiyuan Guben Tongluo Ointment for Elderly Sarcopenia NCT07538674

This document registers a Phase 2 clinical trial on ClinicalTrials.gov, an NIH-maintained registry. The study evaluates a traditional Chinese medicine ointment (Peiyuan Guben Tongluo Ointment, Ejiao concentrated formula) in elderly patients diagnosed with sarcopenia, using DXA scans to measure limb muscle mass changes over 12 weeks. The trial design includes a parallel control arm receiving an agarose-concentrated version of the same ointment.

For pharmaceutical companies and clinical investigators, this registration provides visibility into active research in the sarcopenia therapeutic space. Sponsors developing treatments for age-related muscle loss may wish to monitor competing trial designs and endpoints. The trial does not create compliance obligations for third parties.